Orbit s Portfolio
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease. The term nonsteroidal distinguishes these drugs from steroids, which while having a similar eicosanoid-depressing, anti-inflammatory action, have a broad range of other effects. First used in 1960, the term served to distance these medications from steroids. Below listed the Orbit s Portfolio NAME Aceclofenac 100mg + Paracetamol 325mg +Chlorzoxazone 250/500mg Aceclofenac 100mg + Paracetamol 325mg + Rabeprazole 10 Aceclofenac 100mg + Paracetamol 325mg + Serratiopeptidase 10/15mg Aceclofenac 100mg + Paracetamol 325mg + Thiocolchicoside 4/8 mg Aceclofenac 100mg + Thiocolchicoside 4/8mg Aceclofenac SR 200mg Aceclofenac 100mg+Bromelain 90mg+Trypsin 48mg+Rutoside 100mg Baclofen 10mg Diclofenac Pottasium 50mg+Paracetamol 325mg+Serratiopeptidase-10/15 mg Diclofenac Pottasium 50mg + Serratiopeptidase 10mg Diclofenac Sodium 50mg+Paracetamol 325mg+Chlorzoxazone 250/500mg Diclofenac Sodium 50mg + Thiocolchicoside 4/8 mg Diclofenac Sodium 50mg + Tramadol 37.5mg + Chlorzoxazone 250mg Diclofenac Sodium 50mg+Trypsin 48mg+Bromelain 90mg+Rutoside 100mg Etodolac 300mg + Thiocolchicoside 4mg Etodolac 400mg (ER) 600 mg Etodolac 400mg + Paracetamol 325mg Etodolac 400mg + Thiocolchicoside 4mg Etoricoxib 60/90/120mg Etoricoxib 60/90mg + Thiocolchicoside 4/8 mg Etoricoxib 60mg + Paracetamol 325mg Lafutidine-10mg TYPE
Lornoxicam 4/8/16mg Lornoxicam-4/ 8mg + Paracetamol 325mg Nimesulide 100mg + Paracetamol 325mg + Serratiopeptidase 10mg Nimesulide 100mg + Paracetamol 325mg Nimesulide 100mg + Serratiopeptidase 10mg Paracetamol 325mg + Tramadol 37.5/50mg Piroxicam 20mg Rabeprazole 20mg(Entric Coated Tab.) + Aceclofenac 200mg (SR) Thiocolchicoside 4/8mg Tolperisone HCl 150mg Trypsin 48mg + Bromelain 90mg + Rutoside 100mg Diclofenac Sodium Injection 75 mg/3ml Diclofenac, Linseed Oil, Menthol with Methyl Salicylate Gel 1.16% + 3.0% + 5.0% + 10.0% Diclofenac Gel BP 1% w/w Slow Diclfoenac Tablets 100 mg Diclofenac Sodium with Serratiopeptidase Tablets (50 + 10,000 I.U.) Diclofenac Sodium Injection 25 mg/ml Diclofenac Potassium Tablets USP 50 mg Ibuprofen Tablets BP 200 mg Ibuprofen Tablets BP 400 mg Ibuprofen Tablets BP 600 mg Ibuprofen Tablets BP 800 mg Ibuprofen Oral Suspension BP 100 mg / 5 ml Ibuprofen + Paracetamol Tablets 400 mg + 500 mg Ibuprofen + Paracetamol Tablets 400 mg + 325 mg Aceclofenac Tablets 100 mg Aceclofenac Sustained Release Tablets 200 mg Aceclofenac & Paracetamol Tablets 100 mg + 325 mg Aceclofenac & Paracetamol Tablets 100 mg + 500 mg Indomethazine Capsules 25 mg Indomethacin Sustained Release Capsules 75 mg Paracetamol, Phenylephrine HCL With Chlorpheniramine Maleate Tablets (500 + 5 + 2 mg)
Chlorpheniramine Maleate Tablets BP 4 mg Serratiopeptidase Tablets 10 mg Dexamethasone Tablets USP 0.5 mg Dexemthasone sodium phosphate Injection USP 4 mg/ml Dexamethasone sodium phosphate opthalmic solution USP 0.1 % w/v Dexamehtasone sodium phosphate and neomycin sulphate opthalmmic solution 0.1 % w/v + 0.5 % w/v Prednisolone Tablets 5 mg PrednisoloneTablets 10 mg Hydrocortisone Sodium Succinate for Injection 100 mg Hydrocortisone Acetate cream BP 1% w/w Acetaminophen Oral Suspension 125 mg / 5 ml Piroxicam Capsules 20 mg Tramadol Capsules B.P. 50 mg Tramadol Hydrochloride Tablets 50 mg Tramadol Hydrochloride Sustained Released Capsule 100 MG Tramadol Hydrochloride Injection 50 mg/ ml Tramadol Hydrochloride with Paracetamol Tablets 50 mg +500 mg Tramadol Hydrochloride With Paracetamol Tablets 325 mg +37.5 mg Paracetamol Tablets BP 500 mg Paracetamol Sustained Release Tablets 1000 mg Paracetamol Oral Suspension 125 mg/5 ml Paracetamol Oral Suspension 250 mg/5 ml Paracetamol Infusion 10 mg/ ml-100 ml Meloxicam Tablets BP 7.5 mg Meloxicam Tablets BP 15 mg Mefenamic Acid Tablets 500 mg Diclofenac Tablets BP 25 mg Diclofenac Tablets BP 50 mg Chlorzoxazone, Diclofenac Sodium & Paracetamol Tablets 250 mg + 50 mg + 325 mg Diclofenac Sodium Injection 75 mg/ml Diclofenac Sodium with Paracetamol Tablets 50 mg + 500 mg Each Uncoated tablet contains Aceclofenac 100mg paracetamol.325mg
ABOUT ORBIT Orbit LifeSciences - Pioneer In Delivering Health Outcomes Orbit Lifesciences is on a mission to deliver quality health through its innovative, evolving and growing product portfolio. Launched in 2004, Orbit is a part of Orbit Group. With a strong focus on innovation, speed of execution & extensive networking Today, orbit Lifescience is reckoned as one of the fastest growing, multi-faceted progressive professional organization in building and delivering mutually beneficial business propositions ranging from In-licensing, Out-licensing and Exports of Finished Formulations. This is Orbit Proprietary Material. The information in this document is the property of Orbit or its licensors and is protected by copyright and other intellectual property laws. The information in this document is confidential and may be legally privileged or exempt from disclosure under applicable law and shall not attach any liability on the originator. It is intended solely for the addressee. This document shall and will neither be copied, distributed nor have the contents disseminated to anyone else aside from the addressee, without the prior approval of Alhev Access to this document by anyone else is unauthorized. If you are not the intended recipient, or a person responsible for delivery of this document to an intended recipient, any disclosure, copying, distribution or any action taken or omitted to be taken in reliance on it, is prohibited and may be unlawful. Also, you may not copy, print, store, deliver, disseminate or distribute this document to anyone. If you have received this document in error or in such a case, as described herein, please destroy this document and any copies immediately and notify the sender by email at info@orbit.com When addressed to our clients, any opinions or advice contained in this document are subject to the terms and conditions expressed in the governing Orbit - client engagement letter. While the Orbit team tries its best to keep the information up-to-date in line with the evolving trends, Orbit assumes no responsibility for the validity and correctness of the information provided.